Device company EndoChoice is planning a $100 million to $150 million NASDAQ initial public offering for 2015, according to a Jewish Business News report.
The company has yet to file a prospectus for the IPO. If the IPO goes according to plan, it could result in a valuation of $600 million for EndoChoice, according to the report.